Atlas Capital Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Atlas Capital Advisors LLC

$656 Billion
Q3 2024

A detailed history of Atlas Capital Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 148 shares of REGN stock, worth $103,873. This represents 0.02% of its overall portfolio holdings.

Number of Shares

148

Previous 8,482 98.26%

Holding current value

$103,873

Previous $8.91 Billion 98.25%

% of portfolio

0.02%

Previous 1.16%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$1024.09 - $1201.76 $8.53 Million - $10 Million	-8,334 Reduced 98.26%	148 $156 Million
Q2 2024 Jul 29, 2024	BUY	$883.2 - $1071.19 $7.36 Million - $8.92 Million	8,331 Added 5517.22%	8,482 $8.91 Billion
Q1 2024 Apr 15, 2024	SELL	$902.69 - $993.35 $7.52 Million - $8.28 Million	-8,334 Reduced 98.22%	151 $145 Million
Q2 2023 Aug 15, 2023	SELL	$700.03 - $830.35 $1,400 - $1,660	-2 Reduced 0.02%	8,485 $6.1 Billion
Q3 2022 Nov 08, 2022	SELL	$573.97 - $724.32 $8,609 - $10,864	-15 Reduced 0.18%	8,487 $5.85 Billion
Q2 2022 Aug 16, 2022	BUY	$548.35 - $738.84 $10,967 - $14,776	20 Added 0.24%	8,502 $5.03 Billion
Q1 2022 May 11, 2022	BUY	$595.12 - $698.43 $5,356 - $6,285	9 Added 0.11%	8,482 $5.92 Billion
Q1 2021 May 10, 2021	SELL	$446.73 - $548.2 $132,232 - $162,267	-296 Reduced 3.38%	8,473 $4.01 Million
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $162,622 - $206,713	-340 Reduced 3.73%	8,769 $4.24 Million
Q3 2020 Oct 23, 2020	BUY	$544.75 - $658.21 $288,717 - $348,851	530 Added 6.18%	9,109 $5.1 Million
Q2 2020 Jul 28, 2020	BUY	$493.32 - $643.92 $59,691 - $77,914	121 Added 1.43%	8,579 $5.35 Million
Q1 2018 Apr 18, 2018	BUY	$315.82 - $393.78 $2.67 Million - $3.33 Million	8,458 New	8,458 $0

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Account

Atlas Capital Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History